KR20210060150A - Wound dressing material composition and wound dressing material containing the same - Google Patents

Wound dressing material composition and wound dressing material containing the same Download PDF

Info

Publication number
KR20210060150A
KR20210060150A KR1020190147833A KR20190147833A KR20210060150A KR 20210060150 A KR20210060150 A KR 20210060150A KR 1020190147833 A KR1020190147833 A KR 1020190147833A KR 20190147833 A KR20190147833 A KR 20190147833A KR 20210060150 A KR20210060150 A KR 20210060150A
Authority
KR
South Korea
Prior art keywords
extract
wound
coating composition
oil
wound coating
Prior art date
Application number
KR1020190147833A
Other languages
Korean (ko)
Inventor
이영우
윤준성
Original Assignee
(주)트리젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)트리젠 filed Critical (주)트리젠
Priority to KR1020190147833A priority Critical patent/KR20210060150A/en
Publication of KR20210060150A publication Critical patent/KR20210060150A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a wound dressing composition comprising: 20-60 parts by weight of polyurethane; 1-20 parts by weight of a silicone polymer; and the remaining solvent. The wound dressing composition according to the present invention protects a wound part and maintains a wet environment by being rapidly dried to form a film when coated on skin and alleviates itching, inflammation, and scarring caused by dry skin. In addition, the wound dressing composition according to the present invention has elasticity and flexibility after forming the film, can be maintained on a curved part of the skin for a long time, and allows contact with water such as light shower with a waterproof effect.

Description

창상피복재 조성물 및 이를 포함하는 창상피복재{Wound dressing material composition and wound dressing material containing the same}Wound dressing material composition and wound dressing material containing the same}

본 발명은 창상피복재 조성물 및 이를 포함하는 창상피복재에 관한 것으로, 보다 상세하게는 상처에 도포하면 피막을 형성하여 상처 부위를 보호하고, 습윤 환경을 유지함으로써 건조된 피부로 인한 가려움 내지 흉터 발생을 완화해 줄 수 있는 창상피복재 조성물 및 이를 포함하는 창상피복재에 관한 것이다.The present invention relates to a wound coating composition and a wound coating material comprising the same, and more particularly, when applied to a wound, a film is formed to protect the wound area, and by maintaining a moist environment, itching or scarring caused by dry skin is relieved. It relates to a wound coating composition that can give and a wound coating material comprising the same.

피부의 상처는 기원전부터 동물기름이나 벌꿀, 각종 식물 등을 이용하여 치유하는 것으로 알려져 있다. 1962년 윈터가 상처를 습윤 상태로 유지하는 것이 상처 치유에 더 도움이 된다는 논문을 발표한 이래 다양한 습윤 드레싱(wet dressing)이 개발되었다.Skin wounds have been known to heal from BC using animal oil, honey, and various plants. A variety of wet dressings have been developed since Winter published a paper in 1962 stating that keeping wounds wet is more beneficial for wound healing.

또한, 최근에는 피부의 가벼운 찰과상 등에 사용하기 위한 액상 창상피복재들이 개발되어 사용되고 있다. 여기에는 니트로셀룰로오스, 폴리우레탄, 폴리비닐피롤리돈 또는 아크릴레이트 등이 주재로 사용되고 있다. 이러한 액상 창상피복재를 제조하기 위한 용매로는 물, 에틸아세테이트, 알코올 또는 이소옥탄 등이 사용되고 있다. 그러나 상기 액상 창상피복재들은 상처에 의해 발생할 수 있는 흉터의 완화 기능은 지니고 있지 않으며, 상처의 가려움이나 염증 완화 기능도 없는 것으로 알려져 있다.In addition, recently, liquid wound coverings for use in light abrasions of the skin have been developed and used. Here, nitrocellulose, polyurethane, polyvinylpyrrolidone or acrylate, etc. are mainly used. Water, ethyl acetate, alcohol, isooctane, and the like are used as a solvent for preparing such a liquid wound covering. However, it is known that the liquid wound coverings do not have a function of alleviating scars that may be caused by a wound, and do not have a function of alleviating itchiness or inflammation of a wound.

한편, 일반적으로 상처로 인한 흉터 발생을 완화시켜주기 위하여 실록산 중합체들이 크림, 패취 등의 형태로 사용되고 있다. 그러나 크림의 경우 쉽게 제거되어 피부에 오래 작용하기 어렵고, 패취의 경우에는 신체의 굴곡진 부위 등에서 밀착이 잘 되지 않고 쉽게 떨어지는 단점이 있다. Meanwhile, in general, siloxane polymers are used in the form of creams and patches to alleviate the occurrence of scars caused by wounds. However, in the case of the cream, it is easily removed and it is difficult to act on the skin for a long time. In the case of the patch, there is a disadvantage that it does not adhere well to the curved part of the body and falls off easily.

그러므로 본 발명자는 상술한 종래기술의 문제점을 해결하고자 상처에 도포하면 피막을 형성하여 상처 부위를 보호하고, 습윤 환경을 유지할 수 있는 액상 창상피복재를 개발하기 위한 연구를 거듭한 결과, 폴리우레탄과 실록산 중합체의 혼합물을 용매에 용해시겨 상분리가 일어나지 않는 균일하고 안정한 용액을 제조할 수 있으면, 피부에 도포 시 빠르게 건조되어 피막을 형성할 수 있는 액상 창상피복재로 응용할 수 있음에 착안하여 본 발명을 완성하기에 이르렀다. Therefore, in order to solve the problems of the prior art described above, the inventors have repeatedly researched to develop a liquid wound covering material that can protect the wound area by forming a film when applied to a wound and maintain a moist environment. As a result, polyurethane and siloxane If a mixture of polymers can be dissolved in a solvent to prepare a homogeneous and stable solution that does not cause phase separation, the present invention has been completed by conceiving that it can be applied as a liquid wound coating material that can quickly dry and form a film when applied to skin. It came to the following.

특허문헌 1. 한국등록특허공보 제10-1879643호Patent Document 1. Korean Registered Patent Publication No. 10-1879643 특허문헌 2. 한국등록특허공보 제10-0838428호Patent Document 2. Korean Registered Patent Publication No. 10-0838428

따라서 본 발명은 상기와 같은 문제점을 감안하여 안출된 것으로, 본 발명의 목적은 상처에 도포하면 피막을 형성하여 상처 부위를 보호하고, 습윤 환경을 유지할 수 있는 액상 창상피복재 조성물을 제공하고자 하는 것이다.Accordingly, the present invention has been conceived in view of the above problems, and an object of the present invention is to provide a liquid wound covering composition capable of protecting a wound area by forming a film when applied to a wound and maintaining a moist environment.

또한, 본 발명의 또 다른 목적은 상기 액상 창상피복재 조성물을 포함함으로써 신체의 굴곡진 부위나 복잡한 3차원 구조의 피부에 적용이 용이하고 탄력성 및 유연성을 갖는 창상피복재를 제공하고자 하는 것이다.In addition, another object of the present invention is to provide a wound coating material having elasticity and flexibility, which is easy to apply to a curved part of the body or a complex three-dimensional skin by including the liquid wound coating composition.

상기한 바와 같은 목적을 달성하기 위한 본 발명은, 폴리우레탄 20~60 중량부; 실리콘 중합체 1~20 중량부; 및 잔부의 용매;를 포함하는 창상피복재 조성물을 제공한다. The present invention for achieving the object as described above, 20 to 60 parts by weight of polyurethane; 1 to 20 parts by weight of a silicone polymer; It provides a wound covering composition comprising; and the remainder of the solvent.

상기 실리콘 중합체는 헥사메틸디실록산(HMDSO), 옥타메틸트리실록산(OMTSO), 사이클로펜타실록산(CPSO), 폴리디메틸실록산(PDMS) 및 하이드록시 말단의 폴리디메틸실록산(HTPDMS) 중에서 선택된 어느 하나 또는 2 이상의 혼합물인 것을 특징으로 한다.The silicone polymer is any one or two selected from hexamethyldisiloxane (HMDSO), octamethyltrisiloxane (OMTSO), cyclopentasiloxane (CPSO), polydimethylsiloxane (PDMS), and hydroxy-terminated polydimethylsiloxane (HTPDMS). It is characterized in that it is a mixture of the above.

상기 용매는 물, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올, 펜탄올, 메틸아세테이트, 에틸아세테이트, 프로필아세테이트, 부틸아세테이트, 이소펜틸아세테이트, 디메틸케톤, 메틸에틸케톤, 디에틸케톤, 디이소프로필 아디페이트, 이소프로필 미리스테이트, 이소프로필 팔미테이트, 미네랄오일, 펜탄, 헥산, 헵탄, 옥탄, 이소옥탄, 노난, 데칸 및 이소도데칸 중에서 선택된 어느 하나 또는 2 이상의 혼합 용매인 것을 특징으로 한다.The solvent is water, methanol, ethanol, propanol, isopropanol, butanol, pentanol, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, isopentyl acetate, dimethyl ketone, methyl ethyl ketone, diethyl ketone, diisopropyl adipate. , Isopropyl myristate, isopropyl palmitate, mineral oil, pentane, hexane, heptane, octane, isooctane, nonane, decane, and isododecane.

상기 창상피복재 조성물은 점도 50~1,000 cp, pH 4.5~6.5인 것을 특징으로 한다.The wound coating composition is characterized in that the viscosity is 50 ~ 1,000 cp, pH 4.5 ~ 6.5.

상기 창상피복재 조성물은 퀸즈랜드 넛오일, 솔잎추출물, 고삼추출물, 옥용산추출물, 멘톨, 박하, 민트, 에뮤오일, 베타글루칸, 어성초추출물, 인삼추출물, 느릅나무뿌리추출물, 브로콜리추출물, 고삼추출물, 꽈리열매추출물, 마치현추출물, 우엉추출물, 카렌듈라추출물, 캐모마일추출물, 파파야추출물, 당귀추출물, 시호추출물, 맥문동추출물, 천문동추출물, 침향추출물, 병풀추출물, 감초추출물, 오디추출물, 상백피추출물, 녹차추출물, 마트리카리아꽃추출물, 알로에베라잎추출물, 허브추출물, 감초진액, 올리브오일, 호호바씨오일, 동백꽃오일, 아몬드오일, 로즈마리잎추출물, 소나무추출물, 무궁화씨추출물, 엉겅퀴추출물, 하이드록시에틸우레아, 세라마이드, 1,3-뷰티렌, 1,2-헥산디올 및 베타인으로 이루어진 군으로부터 선택된 1종 이상의 성분을 더욱 포함하는 것을 특징으로 한다.The wound covering composition is queensland nut oil, pine needle extract, gosam extract, okyongsan extract, menthol, peppermint, mint, emu oil, beta glucan, Eoseongcho extract, ginseng extract, elm root extract, broccoli extract, gosam extract, sesame fruit Extract, Portulaca oleracea extract, Burdock extract, Calendula extract, Chamomile extract, Papaya extract, Angelicae extract, Siho extract, Macmundong extract, Cheonmundong extract, Aloes extract, Centella asiatica extract, Licorice extract, Audi extract, Sangbaek skin extract, Green tea extract Flower extract, aloe vera leaf extract, herbal extract, licorice extract, olive oil, jojoba seed oil, camellia flower oil, almond oil, rosemary leaf extract, pine extract, sharon seed extract, thistle extract, hydroxyethylurea, ceramide, 1, It is characterized in that it further comprises at least one component selected from the group consisting of 3-butyrene, 1,2-hexanediol, and betaine.

또한, 본 발명은 상기 창상피복재 조성물을 포함하는 창상피복재를 제공한다.In addition, the present invention provides a wound covering material comprising the wound covering composition.

본 발명에 따른 창상피복재 조성물은 피부에 도포하면 빠르게 건조되어 피막을 형성함으로써 상처 부위를 보호하고 습윤 환경을 유지하며, 건조된 피부로 인한 가려움증 및 염증, 또한 흉터 발생을 완화해 줄 수 있다. 아울러 본 발명에 따른 창상피복재 조성물은 피막형성 후 탄성과 유연성을 지녀 피부의 굴곡진 부위에 오랜 시간 유지될 수 있으며 방수효과가 있어 가벼운 샤워 등 물과의 접촉도 가능하다.When the wound coating composition according to the present invention is applied to the skin, it dries quickly to form a film, thereby protecting the wound area and maintaining a moist environment, and can relieve itching and inflammation caused by dry skin, as well as the occurrence of scars. In addition, since the wound covering composition according to the present invention has elasticity and flexibility after film formation, it can be maintained for a long time in a curved part of the skin, and has a waterproof effect, so that it is possible to contact with water such as a light shower.

이하에서는 본 발명에 따른 창상피복재 조성물 및 이를 포함하는 창상피복재에 관하여 실시예 및 비교예와 함께 상세히 설명하기로 한다.Hereinafter, the wound coating composition according to the present invention and the wound coating material including the same will be described in detail with examples and comparative examples.

먼저, 본 발명에서는 폴리우레탄 20~60 중량부; 실리콘 중합체 1~20 중량부; 및 잔부의 용매;를 포함하는 창상피복재 조성물을 제공한다.First, in the present invention, 20 to 60 parts by weight of polyurethane; 1 to 20 parts by weight of a silicone polymer; It provides a wound covering composition comprising; and the remainder of the solvent.

일반적으로 폴리우레탄은 유연하면서도 기계적 강도가 높은 특성을 갖기 때문에 지난 수십 년간 의료용 고분자소재로서 가장 많이 사용된 생체재료이다. 혈액 및 조직 적합성이 우수하여 인공장기 등의 재료로 사용될 만큼 널리 알려져 있다. 또한, 실리콘 중합체도 인체에 가장 많이 사용되는 검증된 고분자소재로서 분자량 및 가교 정도에 따라 액체에서부터 고체까지 다양한 제형을 갖는다. 게다가 혈액 적합성이 매우 우수하여 역시 인공장기 등의 재료로 광범위하게 이용되고 있다.In general, polyurethane is a biomaterial that has been most widely used as a medical polymer material over the past several decades because it is flexible and has high mechanical strength. It is widely known to be used as a material such as artificial organs due to its excellent blood and tissue compatibility. In addition, silicone polymers are also proven polymer materials that are most commonly used in the human body, and have various formulations from liquid to solid depending on molecular weight and degree of crosslinking. In addition, it has excellent blood compatibility and is also widely used as a material such as artificial organs.

따라서 본 발명에서는 폴리우레탄 및 실리콘 중합체를 창상피복재 조성물의 주재로서 사용하는바, 폴리우레탄은 의료용 그레이드의 상용화된 제품을 사용할 수 있다. Therefore, in the present invention, a polyurethane and a silicone polymer are used as the main material of the wound covering composition, and the polyurethane may be a commercially available product of medical grade.

또한, 상기 실리콘 중합체는 헥사메틸디실록산(HMDSO), 옥타메틸트리실록산(OMTSO), 사이클로펜타실록산(CPSO), 폴리디메틸실록산(PDMS) 및 하이드록시 말단의 폴리디메틸실록산(HTPDMS) 중에서 선택된 어느 하나 또는 2 이상의 혼합물일 수 있다.In addition, the silicone polymer is any one selected from hexamethyldisiloxane (HMDSO), octamethyltrisiloxane (OMTSO), cyclopentasiloxane (CPSO), polydimethylsiloxane (PDMS), and hydroxy-terminated polydimethylsiloxane (HTPDMS). Or it may be a mixture of two or more.

특히, 상기 실리콘 중합체로서 2개의 혼합물을 사용하는 경우, 하나는 그 분자량이 200,000~1,000,000 범위를 갖는 고분자량의 것을, 다른 하나는 100~5,000 범위의 저분자량 실리콘 중합체를 채택하는 것이 액상 창상피복재 조성물의 점도를 조절함과 동시에 흉터 완화 효과를 극대화 할 수 있어 더욱 바람직하다. In particular, when using a mixture of two as the silicone polymer, one having a high molecular weight having a molecular weight in the range of 200,000 to 1,000,000, and the other having a low molecular weight silicone polymer having a range of 100 to 5,000 is adopted as a liquid wound coating composition. It is more preferable because it can maximize the effect of reducing scars while controlling the viscosity of the skin.

이때, 액상의 창상피복재 조성물을 형성하기 위하여 폴리우레탄과 실리콘 중합체를 용해시켜 균일한 용액을 얻을 수 있도록 용매를 사용하는바, 상기 용매로서는 물, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올, 펜탄올, 메틸아세테이트, 에틸아세테이트, 프로필아세테이트, 부틸아세테이트, 이소펜틸아세테이트, 디메틸케톤, 메틸에틸케톤, 디에틸케톤, 디이소프로필 아디페이트, 이소프로필 미리스테이트, 이소프로필 팔미테이트, 미네랄오일, 펜탄, 헥산, 헵탄, 옥탄, 이소옥탄, 노난, 데칸 및 이소도데칸 중에서 선택된 어느 하나 또는 2 이상의 혼합 용매를 바람직하게 사용한다.At this time, a solvent is used to obtain a uniform solution by dissolving polyurethane and silicone polymer to form a liquid wound coating composition. As the solvent, water, methanol, ethanol, propanol, isopropanol, butanol, pentanol, Methyl acetate, ethyl acetate, propyl acetate, butyl acetate, isopentyl acetate, dimethyl ketone, methyl ethyl ketone, diethyl ketone, diisopropyl adipate, isopropyl myristate, isopropyl palmitate, mineral oil, pentane, hexane, Any one or two or more mixed solvents selected from heptane, octane, isooctane, nonane, decane, and isododecane are preferably used.

본 발명에 따른 액상 창상피복재 조성물은 상기 폴리우레탄을 20~60 중량부로, 실리콘 중합체를 1~20 중량부로, 나머지는 잔부의 용매를 포함하여 형성하는 것이 궁극적으로 액상 밴드 타입의 창상피복재로 바람직하게 제조될 수 있다.The liquid wound coating composition according to the present invention is preferably formed of 20 to 60 parts by weight of the polyurethane, 1 to 20 parts by weight of the silicone polymer, and the remainder of the solvent as a liquid band-type wound coating material. Can be manufactured.

상술한 바와 같이 형성되는 액상 창상피복재 조성물은 점도 50~1,000 cp, pH 4.5~6.5인 것이 피부에 도포하면 빠르게 건조되어 피막을 형성함으로써 상처 부위를 보호하고 습윤 환경을 유지하며, 건조된 피부로 인한 가려움증 및 염증, 또한 흉터 발생을 완화해 줄 수 있어 더욱 바람직하다.The liquid wound covering composition formed as described above has a viscosity of 50 to 1,000 cp and a pH of 4.5 to 6.5. When applied to the skin, it dries quickly and forms a film to protect the wound area and maintain a moist environment. It is more preferable because it can relieve itching and inflammation, and scarring.

또한, 본 발명에 따른 창상피복재 조성물은 가려움증 내지 염증 완화, 피부진정, 소독 및 보습 효과 등을 얻기 위하여 기능성 성분을 더욱 포함할 수 있는바, 가려움증 완화를 위하여 퀸즈랜드 넛오일, 솔잎추출물, 고삼추출물, 옥용산추출물, 멘톨, 박하 또는 민트, 염증 완화를 위하여 에뮤오일, 베타글루칸, 어성초추출물, 인삼추출물, 느릅나무뿌리추출물, 브로콜리추출물, 고삼추출물, 꽈리열매추출물, 마치현추출물, 우엉추출물, 카렌듈라추출물, 캐모마일추출물, 파파야추출물, 당귀추출물, 시호추출물, 맥문동추출물, 천문동추출물 또는 침향추출물, 피부진정을 위하여 병풀추출물, 감초추출물, 오디추출물, 상백피추출물, 녹차추출물, 마트리카리아꽃추출물, 알로에베라잎추출물, 허브추출물, 감초진액, 보습을 위하여 올리브오일, 호호바씨오일, 동백꽃오일, 아몬드오일, 로즈마리잎추출물, 소나무추출물, 무궁화씨추출물, 엉겅퀴추출물, 하이드록시에틸우레아, 세라마이드, 1,3-뷰티렌, 1,2-헥산디올 및 베타인으로 이루어진 군으로부터 선택된 1종 이상의 성분을 더욱 포함하는 것이 바람직하다.In addition, the wound covering composition according to the present invention may further contain functional ingredients to obtain itchiness or inflammation relief, skin soothing, disinfecting and moisturizing effects, etc., for alleviating itching, Queensland nut oil, pine needle extract, high ginseng extract, Okyongsan extract, menthol, peppermint or mint, emu oil, beta-glucan, Eoseongcho extract, ginseng extract, elm tree root extract, broccoli extract, gosam extract, perilla fruit extract, mascot extract, burdock extract, calendula extract, Chamomile extract, papaya extract, angelica extract, siho extract, licorice extract, astronomical dong extract or aloe vera extract, centella asiatica extract, licorice extract, mulberry extract for skin soothing, lettuce extract, green tea extract, matricaria flower extract, aloe vera , Herb extract, licorice essence, olive oil, jojoba seed oil, camellia flower oil, almond oil, rosemary leaf extract, pine extract, sharon seed extract, thistle extract, hydroxyethylurea, ceramide, 1,3-butyrene for moisturizing It is preferable to further include at least one component selected from the group consisting of 1,2-hexanediol and betaine.

또한, 본 발명에서는 상술한 창상피복재 조성물을 포함하여 공지의 방법에 따라 액상 밴드 타입으로 성형함으로써 창상피복재를 제공할 수 있다.In addition, in the present invention, it is possible to provide a wound covering material by molding into a liquid band type according to a known method, including the wound covering composition described above.

이하 본 발명에 따른 구체적인 실시예를 비교예와 함께 상세히 설명한다.Hereinafter, specific examples according to the present invention will be described in detail together with comparative examples.

[실시예][Example]

(제조예 1-5)(Production Example 1-5)

폴리우레탄 용액(40 중량%, 용매는 에탄올/이소프로필 팔미테이트)에 아래 표 1에서 나타낸 다양한 실리콘 중합체가 혼합된 액상의 창상피복재 조성물을 형성하였다.A liquid wound coating composition was formed in which various silicone polymers shown in Table 1 below were mixed in a polyurethane solution (40% by weight, solvent: ethanol/isopropyl palmitate).

제조예Manufacturing example 폴리우레탄 함량(중량부)Polyurethane content (parts by weight) 실리콘 중합체 함량(중량부)Silicone polymer content (parts by weight) 제조예 1Manufacturing Example 1 1010 0.3(PDMS)0.3 (PDMS) 제조예 2Manufacturing Example 2 1010 0.3(HTPDMS)0.3 (HTPDMS) 제조예 3Manufacturing Example 3 1010 0.3(HMDSO)0.3 (HMDSO) 제조예 4Manufacturing Example 4 1010 0.3(OMTSO)0.3 (OMTSO) 제조예 5Manufacturing Example 5 1010 0.3(CPSO)0.3 (CPSO)

(제조예 6-10)(Production Example 6-10)

상기 제조예 1로부터 얻어진 액상의 창상피복재 조성물에 아래 표 2에서 나타낸 다양한 염증 완화 성분을 첨가하여 액상의 창상피복재 조성물을 형성하였다.To the liquid wound coating composition obtained from Preparation Example 1, various inflammation alleviating components shown in Table 2 were added to form a liquid wound coating composition.

제조예Manufacturing example 제조예 1의 조성물 함량(중량부)Composition content of Preparation Example 1 (parts by weight) 염증 완화 성분 함량(중량부)Inflammation relief component content (parts by weight) 제조예 6Manufacturing Example 6 10.310.3 0.043(에뮤오일)0.043 (emu oil) 제조예 7Manufacturing Example 7 10.310.3 0.043(베타글루칸)0.043 (betaglucan) 제조예 8Manufacturing Example 8 10.310.3 0.043(어성초추출물)0.043 (Eoseongcho extract) 제조예 9Manufacturing Example 9 10.310.3 0.043(고삼추출물)0.043 (Gosam extract) 제조예 10Manufacturing Example 10 10.310.3 0.043(캐모마일추출물)0.043 (chamomile extract)

(제조예 11-15)(Production Example 11-15)

상기 제조예 10으로부터 얻어진 액상의 창상피복재 조성물에 아래 표 3에서 나타낸 다양한 가려움증 완화 성분을 첨가하여 액상의 창상피복재 조성물을 형성하였다.A liquid wound coating composition was formed by adding various itching relief ingredients shown in Table 3 below to the liquid wound coating composition obtained from Preparation Example 10.

제조예Manufacturing example 제조예 10의 조성물 함량(중량부)Composition content of Preparation Example 10 (parts by weight) 가려움증 완화 성분 함량(중량부)Content of itching relief ingredients (parts by weight) 제조예 11Manufacturing Example 11 10.34310.343 0.02(퀸즈랜드 넛오일)0.02 (Queensland Nut Oil) 제조예 12Manufacturing Example 12 10.34310.343 0.02(솔잎추출물)0.02 (pine needle extract) 제조예 13Manufacturing Example 13 10.34310.343 0.02(멘톨)0.02 (menthol) 제조예 14Manufacturing Example 14 10.34310.343 0.02(옥용산추출물)0.02 (Okyongsan extract) 제조예 15Manufacturing Example 15 10.34310.343 0.02(민트)0.02 (mint)

(제조예 16-20)(Production Example 16-20)

상기 제조예 11로부터 얻어진 액상의 창상피복재 조성물에 아래 표 4에서 나타낸 다양한 피부 진정 성분을 첨가하여 액상의 창상피복재 조성물을 형성하였다.Various skin soothing ingredients shown in Table 4 below were added to the liquid wound coating composition obtained from Preparation Example 11 to form a liquid wound coating composition.

제조예Manufacturing example 제조예 11의 조성물 함량(중량부)Composition content of Preparation Example 11 (parts by weight) 피부 진정 성분 함량(중량부)Skin soothing ingredient content (parts by weight) 제조예 16Manufacturing Example 16 10.36310.363 0.04(병풀추출물)0.04( Centella asiatica extract) 제조예 17Manufacturing Example 17 10.36310.363 0.04(감초추출물)0.04 (Liquorice extract) 제조예 18Manufacturing Example 18 10.36310.363 0.04(녹차추출물)0.04 (green tea extract) 제조예 19Manufacturing Example 19 10.36310.363 0.04(알로에베라추출물)0.04 (Aloe vera extract) 제조예 20Manufacturing Example 20 10.36310.363 0.04(당귀추출물)0.04(Angelicae extract)

(제조예 21-25)(Production Example 21-25)

상기 제조예 16으로부터 얻어진 액상의 창상피복재 조성물에 아래 표 5에서 나타낸 다양한 보습 성분을 첨가하여 액상의 창상피복재 조성물을 형성하였다.Various moisturizing components shown in Table 5 below were added to the liquid wound coating composition obtained from Preparation Example 16 to form a liquid wound coating composition.

제조예Manufacturing example 제조예 16의 조성물 함량(중량부)Composition content of Preparation Example 16 (parts by weight) 보습 성분 함량(중량부)Moisturizing ingredient content (parts by weight) 제조예 21Manufacturing Example 21 10.40310.403 0.04(올리브오일)0.04 (olive oil) 제조예 22Manufacturing Example 22 10.40310.403 0.04(호호바씨오일)0.04(Jojoba seed oil) 제조예 23Manufacturing Example 23 10.40310.403 0.04(동백꽃오일)0.04 (camellia flower oil) 제조예 24Manufacturing Example 24 10.40310.403 0.04(하이드록시에틸우레아)0.04 (hydroxyethylurea) 제조예 25Manufacturing Example 25 10.40310.403 0.04(세라마이드)0.04 (ceramide)

상기 제조예 1 내지 20으로부터 얻어진 액상의 창상피복재 조성물은 담황색을 띄며 투명하고 점성이 있는 용액 상태로서 피부에 도포하기 용이한 브러시, 스패츌러 타입의 캔으로 형성된 유리용기에 보관하여 사용할 수 있다. The liquid wound covering composition obtained from Preparation Examples 1 to 20 has a pale yellow color, is a transparent and viscous solution, and can be stored and used in a glass container formed of a brush or spatula type can that is easy to apply to the skin.

(시험예)(Test Example)

상기 제조예 21로부터 얻어진 액상의 창상피복재 조성물을 캐스팅하고 완전히 건조한 후 필름 형상의 창상피복재를 제조하였으며, 이렇게 제조한 필름 형상의 창상피복재와 상업화된 기존의 액상 밴드로부터 제조한 필름(비교예 1 : 폴리우레탄계, 비교예 2 : 니트로셀룰로오스계)을 대상으로 인장강도, 연신율 및 투습도(WVTR @36℃)를 측정하여 그 결과를 아래 표 6에 나타내었다.The liquid wound covering composition obtained from Preparation Example 21 was cast and completely dried to prepare a film-shaped wound covering, and a film prepared from the thus prepared film-shaped wound covering and the conventional liquid band commercialized (Comparative Example 1: Polyurethane-based, Comparative Example 2: nitrocellulose-based) were measured for tensile strength, elongation and moisture permeability (WVTR @36°C), and the results are shown in Table 6 below.

물성Properties 시험예Test example 비교예 1Comparative Example 1 비교예 2Comparative Example 2 인장강도(Mpa)Tensile strength (Mpa) 13.713.7 19.219.2 8.58.5 연신율(%)Elongation (%) 711.64711.64 768.3768.3 35.6535.65 WVTR(g/m2day)WVTR(g/m 2 day) 2,0402,040 1,2401,240 300300 pH*pH* 4.854.85 7.877.87 3.013.01

*pH는 액상의 창상피복재 조성물을 측정한 값*pH is the measured value of the liquid wound covering composition

상기 표 6에서 보는 바와 같이, 본 발명에 따른 액상의 창상피복재 조성물로부터 제조된 창상피복재는 인장강도 및 연신율과 같은 기계적 특성이 우수할 뿐만 아니라, 투습도가 상업화된 기존 제품에 비하여 크게 상승하여 습윤 환경을 유지할 수 있고, 다양한 기능성 성분이 첨가됨으로써 가려움증 및 염증의 완화, 보습 및 피부 진정 효과를 거둘 수 있다.As shown in Table 6, the wound coating material prepared from the liquid wound coating composition according to the present invention not only has excellent mechanical properties such as tensile strength and elongation, but also has a greater moisture permeability compared to the commercially available conventional products, resulting in a wet environment. It can maintain, and by the addition of various functional ingredients, itching and inflammation can be relieved, moisturizing and skin soothing effects can be obtained.

Claims (6)

폴리우레탄 20~60 중량부;
실리콘 중합체 1~20 중량부; 및
잔부의 용매;를 포함하는 창상피복재 조성물.
20 to 60 parts by weight of polyurethane;
1 to 20 parts by weight of a silicone polymer; And
The balance of the solvent; wound coating composition containing.
제1항에 있어서, 상기 실리콘 중합체는 헥사메틸디실록산(HMDSO), 옥타메틸트리실록산(OMTSO), 사이클로펜타실록산(CPSO), 폴리디메틸실록산(PDMS) 및 하이드록시 말단의 폴리디메틸실록산(HTPDMS) 중에서 선택된 어느 하나 또는 2 이상의 혼합물인 것을 특징으로 하는 창상피복재 조성물.The method of claim 1, wherein the silicone polymer is hexamethyldisiloxane (HMDSO), octamethyltrisiloxane (OMTSO), cyclopentasiloxane (CPSO), polydimethylsiloxane (PDMS), and hydroxy-terminated polydimethylsiloxane (HTPDMS). Wound coating composition, characterized in that any one or a mixture of two or more selected from. 제1항에 있어서, 상기 용매는 물, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올, 펜탄올, 메틸아세테이트, 에틸아세테이트, 프로필아세테이트, 부틸아세테이트, 이소펜틸아세테이트, 디메틸케톤, 메틸에틸케톤, 디에틸케톤, 디이소프로필 아디페이트, 이소프로필 미리스테이트, 이소프로필 팔미테이트, 미네랄오일, 펜탄, 헥산, 헵탄, 옥탄, 이소옥탄, 노난, 데칸 및 이소도데칸 중에서 선택된 어느 하나 또는 2 이상의 혼합 용매인 것을 특징으로 하는 창상피복재 조성물.The method of claim 1, wherein the solvent is water, methanol, ethanol, propanol, isopropanol, butanol, pentanol, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, isopentyl acetate, dimethyl ketone, methyl ethyl ketone, diethyl ketone. , Diisopropyl adipate, isopropyl myristate, isopropyl palmitate, mineral oil, pentane, hexane, heptane, octane, isooctane, nonane, decane, and isododecane. The wound covering composition. 제1항에 있어서, 상기 창상피복재 조성물은 점도 50~1,000 cp, pH 4.5~6.5인 것을 특징으로 하는 창상피복재 조성물.The wound coating composition according to claim 1, wherein the wound coating composition has a viscosity of 50 to 1,000 cp and a pH of 4.5 to 6.5. 제1항에 있어서, 상기 창상피복재 조성물은 퀸즈랜드 넛오일, 솔잎추출물, 고삼추출물, 옥용산추출물, 멘톨, 박하, 민트, 에뮤오일, 베타글루칸, 어성초추출물, 인삼추출물, 느릅나무뿌리추출물, 브로콜리추출물, 고삼추출물, 꽈리열매추출물, 마치현추출물, 우엉추출물, 카렌듈라추출물, 캐모마일추출물, 파파야추출물, 당귀추출물, 시호추출물, 맥문동추출물, 천문동추출물, 침향추출물, 병풀추출물, 감초추출물, 오디추출물, 상백피추출물, 녹차추출물, 마트리카리아꽃추출물, 알로에베라잎추출물, 허브추출물, 감초진액, 올리브오일, 호호바씨오일, 동백꽃오일, 아몬드오일, 로즈마리잎추출물, 소나무추출물, 무궁화씨추출물, 엉겅퀴추출물, 하이드록시에틸우레아, 세라마이드, 1,3-뷰티렌, 1,2-헥산디올 및 베타인으로 이루어진 군으로부터 선택된 1종 이상의 성분을 더욱 포함하는 것을 특징으로 하는 창상피복재 조성물.The method of claim 1, wherein the wound covering composition is Queensland nut oil, pine needle extract, gosam extract, Okyongsan extract, menthol, mint, mint, emu oil, beta glucan, Eoseongcho extract, ginseng extract, elm tree root extract, broccoli extract , Sophora ginseng extract, Japanese ginseng fruit extract, portulaca oleracea extract, burdock extract, calendula extract, chamomile extract, papaya extract, angelica extract, shiho extract, licorice extract, cheonmundong extract, aloes extract, centella extract, mulberry extract, licorice extract Green Tea Extract, Matricaria Flower Extract, Aloe Vera Leaf Extract, Herb Extract, Licorice Extract, Olive Oil, Jojoba Seed Oil, Camellia Flower Oil, Almond Oil, Rosemary Leaf Extract, Pine Extract, Mugunghwa Seed Extract, Thistle Extract, Hydroxyethyl Urea, ceramide, 1,3-butyrene, 1,2-hexanediol, and wound coating composition, characterized in that it further comprises at least one component selected from the group consisting of betaine. 제1항 내지 제5항 중 어느 한 항의 창상피복재 조성물을 포함하는 창상피복재.The wound coating material comprising the wound coating composition of any one of claims 1 to 5.
KR1020190147833A 2019-11-18 2019-11-18 Wound dressing material composition and wound dressing material containing the same KR20210060150A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190147833A KR20210060150A (en) 2019-11-18 2019-11-18 Wound dressing material composition and wound dressing material containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190147833A KR20210060150A (en) 2019-11-18 2019-11-18 Wound dressing material composition and wound dressing material containing the same

Publications (1)

Publication Number Publication Date
KR20210060150A true KR20210060150A (en) 2021-05-26

Family

ID=76137648

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190147833A KR20210060150A (en) 2019-11-18 2019-11-18 Wound dressing material composition and wound dressing material containing the same

Country Status (1)

Country Link
KR (1) KR20210060150A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220128116A (en) * 2021-03-12 2022-09-20 포항공과대학교 산학협력단 Bioadhesive tape comprising mussel adhesive protein and preparation method thereof
KR102510213B1 (en) 2022-09-30 2023-03-15 아람휴비스 주식회사 The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100838428B1 (en) 2004-06-03 2008-06-16 알케어캄파니리미티드 Pressure-Sensitive Adhesive Covering Material for Application to Skin
KR101879643B1 (en) 2017-02-22 2018-07-18 주식회사 원바이오젠 Spray-type soft-melting polyurethane foam wound dressing and producing method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100838428B1 (en) 2004-06-03 2008-06-16 알케어캄파니리미티드 Pressure-Sensitive Adhesive Covering Material for Application to Skin
KR101879643B1 (en) 2017-02-22 2018-07-18 주식회사 원바이오젠 Spray-type soft-melting polyurethane foam wound dressing and producing method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220128116A (en) * 2021-03-12 2022-09-20 포항공과대학교 산학협력단 Bioadhesive tape comprising mussel adhesive protein and preparation method thereof
KR102510213B1 (en) 2022-09-30 2023-03-15 아람휴비스 주식회사 The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract

Similar Documents

Publication Publication Date Title
KR101774342B1 (en) Hydrogel maskpack composition, Hydrogel maskpack and the preparing method thereof
KR101985368B1 (en) A Hydrogel Composition Excellent In Moisture Resistance And A Sheet Using The Composition
US7666859B2 (en) Skin compositions containing hydrocortisone
Thangavel et al. Topical administration of pullulan gel accelerates skin tissue regeneration by enhancing collagen synthesis and wound contraction in rats
KR101262557B1 (en) Natural korean herb cosmetic
KR20210060150A (en) Wound dressing material composition and wound dressing material containing the same
JP6060084B2 (en) Composition for the treatment of peripheral ulcers of various causes
CN114010532A (en) Double-agent unidirectional slow-release skin repairing film and preparation method and application thereof
US20110081401A1 (en) Dermal patch comprising chondrus crispus extract
US4393045A (en) Cosmetic composition
GB2543091A (en) A topical herbal healing formulation
KR20130028293A (en) A preparation method of multi-pore patch-type cosmetic composition for skin improvement by using emulsifying and lyophilization and a multi-pore patch-type cosmetic composition for skin improvement prepared by the same
CN104083590B (en) Aloe barbadensis Miller composition gels freeze-dried powder external use plaster and preparation method thereof
KR102186254B1 (en) Cosmetic composition containing the natural complex extraction using supercuritical extraction for skin antiaging and skin-whitening
KR20190068363A (en) Cosmetic composition for skin Humectant comprising Opuntia Ficus-Indica fruit extract and mixed compound of panthenol, hyaluronic acid and betaine
KR102274295B1 (en) Composition for applying to skin externally
KR20110052095A (en) Cosmetic composition for moisturizing of skin containing tremella fuciformis extracts
KR102429712B1 (en) Cosmetic ampoul composition comprising noni fruit extract and noni seed oil
KR101064038B1 (en) Cosmetic composition to relieve skin swelling
KR101269993B1 (en) Cosmetic Composition
CN108853369B (en) Preparation method and application of natural plant antibacterial liquid PAMs hydrogel patch
KR102510213B1 (en) The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract
KR20210132346A (en) Cosmetic composition for salleviating skin itching and preventing or improving skin damage due to burns
KR20200089494A (en) Composition for cosmetics comprising 3 kinds of Centella Asiatica extract extract, Hydroxyethyl Urea and Triple Hyaluronic Acid
KR102462647B1 (en) Mask sheet for improving skin elasticity and for whitening

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E601 Decision to refuse application